<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> plays an important role in the <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, but the underlying mechanisms are not fully understood </plain></SENT>
<SENT sid="1" pm="."><plain>Here we examined, in vivo and in vitro, whether <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> involves <z:hpo ids='HP_0011420'>death</z:hpo>-inducing ligand/receptor systems such as CD95 and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand (TRAIL) </plain></SENT>
<SENT sid="2" pm="."><plain>After reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in adult rats, both CD95 ligand and TRAIL were expressed in the apoptotic areas of the postischemic brain </plain></SENT>
<SENT sid="3" pm="."><plain>Further recombinant CD95 ligand and TRAIL proteins induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in primary neurons and neuron-like cells in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi> FK506, which most effectively protects against ischemic <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo>, prevented postischemic expression of these <z:hpo ids='HP_0011420'>death</z:hpo>-inducing ligands both in vivo and in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>FK506 also abolished phosphorylation, but not expression, of the c-Jun transcription factor involved in the transcriptional control of CD95 ligand </plain></SENT>
<SENT sid="6" pm="."><plain>Most importantly, in lpr mice expressing dysfunctional CD95, reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulted in <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes significantly smaller than those found in <z:mp ids='MP_0002169'>wild-type</z:mp> animals </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest an involvement of CD95 ligand and TRAIL in the pathophysiology of postischemic <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> and offer alternative strategies for the treatment of cardiovascular <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e> </plain></SENT>
</text></document>